The mechanisms responsible for these differences in intracellular signaling are unclear, but could in part relate to differences in mechanisms that control p42/44MAPK and SMAD3 expression and activity in DCIS.com cells and SUM225 cells. Here, SMAD3 is linked to ductal breast carcinoma in situ.